Provision of Community Intravenous Therapy Service

The procurement process involves the NHS Greater Manchester Integrated Care Board contracting for a Community Intravenous Therapy Service, under the health services category. This initiative, valued at £3,087,540, aims to provide Intravenous Therapy and Bisphosphonates Service in the Greater Manchester area, specifically Stockport, starting on 1 April 2026 for an initial term of three years, with an extension option up to 31 March 2031. The contract was awarded as part of the Health Care Services (Provider Selection Regime) Regulations 2023 and marked as complete under an open procurement method.

The formal award of the contract is intended to take place following a standstill period ending on 6 October 2025. This procurement provides significant opportunities for businesses in the healthcare sector, especially those specialising in community-based healthcare services. The service aims to improve patient care by reducing hospital admissions and supporting early discharges.

Companies that can offer high-quality intravenous therapy services in a community or home setting, and have robust financial models, could benefit from this tender. Suitable businesses are likely to be those with the capability to manage and deliver health services effectively outside traditional hospital environments, thereby addressing the specific needs outlined by the NHS Greater Manchester Integrated Care Board.